Compare FTK & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTK | MLAB |
|---|---|---|
| Founded | 1985 | 1982 |
| Country | United States | United States |
| Employees | N/A | 730 |
| Industry | Major Chemicals | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.1M | 533.0M |
| IPO Year | 1997 | 1995 |
| Metric | FTK | MLAB |
|---|---|---|
| Price | $20.35 | $104.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $20.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 241.1K | 95.5K |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | ★ 147.06 | 99.24 |
| EPS | 0.12 | ★ 1.95 |
| Revenue | ★ $136,092,000.00 | N/A |
| Revenue This Year | $13.33 | $6.07 |
| Revenue Next Year | $16.38 | $5.41 |
| P/E Ratio | $167.00 | ★ $51.22 |
| Revenue Growth | ★ 214.53 | N/A |
| 52 Week Low | $10.96 | $59.63 |
| 52 Week High | $20.63 | $115.35 |
| Indicator | FTK | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 70.75 | 56.64 |
| Support Level | $15.20 | $70.09 |
| Resistance Level | N/A | $107.88 |
| Average True Range (ATR) | 1.27 | 4.72 |
| MACD | 0.38 | -0.65 |
| Stochastic Oscillator | 92.82 | 57.13 |
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.